BOXBOROUGH MA. –RedShiftBioAnalytics, Inc. (RedShiftBio), a provider of innovative analytical solutions for the measurement of protein characterization and protein concentration used in biotherapeutic drug development and manufacturing, proudly announces the appointment of Tom O’Lenic as its new Chief Executive Officer (CEO). With over two decades of experience in commercial leadership and management roles, O’Lenic brings […]

WALTHAM, Mass. — NanoMosaic, the multiplex and multi-omic quantification company, today announced the expanded capabilities and availability of assays optimized on its Tessie™ system for use in gene therapy applications. The platform combines the ability to quantify proteins and nucleic acids in a single run, enabling the simultaneous detection and characterization of adeno-associated virus (AAV) […]

Universidad de Costa Rica is live on SOPHiA GENETICS’ technology Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Universidad de Costa Rica El Centro de Investigación en Cirugía y Cáncer (CICICA) is now live on the SOPHiA DDM™ […]

Validated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and quantification addresses the unique challenges faced by vaccine developers and manufacturers. BOULDER, CO InDevR Inc., a global leader in vaccine testing and multiplexed assay development for vaccine manufacturers, is excited to announce the launch of OmniFlu HA, a validated, off-the-shelf kit for seasonal influenza vaccine […]

Precision Dx Products are CE-marked and compliant with EU IVDR 2017/746 regulations Precision Dx Products include Twist Precision Prep and Enrichment Dx Kit, Twist Precision Exome Dx Panel and Twist Precision Exome Dx Kit SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality […]

IRVINE, Calif. — In a groundbreaking development, Zymo Research, a leader in biotechnology innovation, has revolutionized large-scale production of animal-free recombinant RNase A (PureRec RNase A), a challenge that persisted for over half a century. This breakthrough will enable the widespread use of recombinant RNase A in applications where an animal-free enzyme is preferred. RNase […]

bit.bio announces first project within multi-year collaboration agreement with The Michael J. Fox Foundation (MJFF) to generate human cell products for research and drug discovery in Parkinson’s disease First project will prioritise the discovery and development of a key human cell type for Parkinson’s disease (PD) research and drug discovery. Collaboration agreement allows MJFF to […]

KITCHENER, ON, CANADA — Nicoya Lifesciences Inc., a pioneering life sciences instrument company specializing in innovative biosensor technologies, is pleased to announce the launch of flexible software configuration packages for their flagship Alto™ Digital Surface Plasmon Resonance (Digital SPR™) system. These packages are designed to provide access to the innovative Alto system at a cost-effective price […]

InDevR Inc., a global leader in vaccine analytical tools and method development, is excited to announce the launch of its latest offering, Expert Services. Expert Services provides vaccine manufacturers with tailored workflow solutions to help address and eliminate development bottlenecks and accelerate the analysis and validation of seasonal vaccines and novel biotherapeutics. Expert Services is InDevR’s latest […]

NEWARK, Calif. — ACROBiosystems, one of the leading providers of innovative tools and solutions used from discovery to the clinic, has announced a new corporate initiative to support ex vivo cell manufacturing and manufacturers of innovative cell and gene therapies. In response to the shifting landscape of biologics manufacturing across the globe, this initiative is designed to […]